About Mahamaya Lifesciences
The shares listed at ₹116.00, a 1.75% move from the issue price. Mahamaya Lifesciences is a SME IPO with an issue size of ₹70.44 crore, proposed for listing on BSE SME. The offer opens on 11th Nov 2025 and closes on 13th Nov 2025. The issue structure includes a fresh issue of ₹60.75 crore and an offer-for-sale component of ₹6.16 crore. The current listing schedule points to 18th Nov 2025.
Company Contact
Address—
Phone—
Websitehttps://www.ipomatrix.com/